Unknown

Dataset Information

0

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase.


ABSTRACT: Phenylketonuria (PKU) is an inherited metabolic disorder caused by mutation within phenylalanine hydroxylase (PAH) gene. Loss-of-function of PAH leads to accumulation of phenylalanine in the blood/body of an untreated patient, which damages the developing brain, causing severe mental retardation. Current gene therapy strategies based on adeno-associated vector (AAV) delivery of PAH gene were effective in male animals but had little long-term effects on blood hyperphenylalaninemia in females. Here, we designed a gene therapy strategy using AAV to deliver a human codon-optimized phenylalanine amino lyase in a liver-specific manner. It was shown that PAL was active in lysing phenylalanine when it was expressed in mammalian cells. We produced a recombinant adeno-associated vector serotype 8 (AAV8) viral vector expressing the humanized PAL under the control of human antitrypsin (hAAT) promoter (AAV8-PAL). A single intravenous administration of AAV8-PAL caused long-term correction of hyperphenylalaninemia in both male and female PKU mice (strain Pahenu2). Besides, no obvious liver injury was observed throughout the treatment process. Thus, our results established that AAV-mediated liver delivery of PAL gene is a promising strategy in the treatment of PKU.

SUBMITTER: Tao R 

PROVIDER: S-EPMC7733040 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC26785 | biostudies-literature
| S-EPMC2795033 | biostudies-literature
| S-EPMC3205297 | biostudies-literature
| S-SCDT-EMM-2021-14649 | biostudies-other
| S-EPMC2634911 | biostudies-literature
| S-EPMC5345807 | biostudies-literature
| S-EPMC9118528 | biostudies-literature
| S-EPMC9081908 | biostudies-literature
| S-EPMC5543251 | biostudies-other
| S-EPMC534739 | biostudies-literature